tert-Butyl 3-bromo-6-formyl-1H-indole-1-carboxylate

Catalog No.: 
ACSDOG377
CAS No.: 
1428866-18-5
Molecular Formula: 
C14H14BrNO3
Molecular Weight: 
324.17
tert-Butyl 3-bromo-6-formyl-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$181.00In stockIn stock
1g98%$423.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromo-6-formyl-1H-indole-1-carboxylate
IUPAC Nametert-Butyl 3-bromo-6-formyl-1H-indole-1-carboxylate
MDL No.MFCD22199348
Molecular FormulaC14H14BrNO3
Molecular Weight324.17
SMILESO=C(N1C=C(Br)C2=C1C=C(C=O)C=C2)OC(C)(C)C
InChI KeySGQSLHQTQWHYER-UHFFFAOYSA-N
Synonymtert-Butyl 3-bromo-6-formyl-1H-indole-1-carboxylate;SGQSLHQTQWHYER-UHFFFAOYSA-N;1H-Indole-1-carboxylic acid, 3-bromo-6-formyl-, 1,1-dimethylethyl ester
CAS No.1428866-18-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSDOG377 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIJSM712 route compound structure diagram
    ACIJSM7121372096-39-3
  4. Then
  5. ACSDOG377 route product structure diagram
    ACSDOG3771428866-18-5In Stock
Inquiry

2. ACSDOG377 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDOG377 route product structure diagram
    ACSDOG3771428866-18-5In Stock
Inquiry

3. ACSDOG377 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDOG377 route product structure diagram
    ACSDOG3771428866-18-5In Stock
Inquiry

Comments (0)